Infectious Disease Archives | Page 2 of 7 | Certara

Publication

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

CertaraJanuary 17, 2020

Poster

Population Pharmacokinetics of Piperacillin-Tazobactam Extended Infusions in Paediatric Population

CertaraJune 24, 2019

Poster

Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV

CertaraJune 24, 2019

Publication

A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole

CertaraJuly 1, 2018

Publication

Pharmacokinetics of Praziquantel in Schistosoma Mansoni- and Schistosoma Haematobium-infected School- and Preschool-aged Children

CertaraJune 4, 2018

Publication

Population Pharmacokinetics of Intravenous Linezolid in Premature Infants

CertaraApril 9, 2018

Publication

Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations

CertaraApril 1, 2018

Publication

Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function

CertaraApril 1, 2018

Blog

Using a pharmacology to payer framework to support product development

Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…

CertaraMarch 16, 2018

Publication

Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics

CertaraMarch 1, 2018

© 2026 Certara. All Rights Reserved. | Legal | Privacy policy